Li Q,Xiang M*. Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy. Acta Pharmacol Sin. 2021 Sep 24. doi: 10.1038/s41401-021-00776-4.
Release time:2022-11-12
Hits:
- Pre One:Yang K, Tian C, Zhang C,Xiang M*. The Controversial Role of IL-33 in Lung Cancer.Front Immunol. 2022;13:897356. 2022 May 12. doi:10.3389/fimmu.2022.897356.
- Next One:Tian C,Xiang M*.Therapeutic agents against COVID-19 with clinical evidence.Curr Pharm Des. 2021, Jan 14;27:1-10.doi: 10.2174/1381612827666210114150951. (* correspondence author)